Role of Poly Unsaturated Fatty Acids (PUFAs) in the management of Paroxysmal Atrial Fibrillation (PAF)

Registry ID

EUCTR2006-006863-22

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE4

Sponsor

University Hospital of South Manchester NHS Foundation Trust

Start date

2007-09-24

Completion date

2009-09-14

Last update

2026-08-16

Conditions

• Paroxysmal Atrial Fibrillation

Summary

To assess the effect of oral supplementation of PUFAs on the frequency and duration of AF episodes in patients known to have paroxysmal atrial fibrillation with a high (≥10%) AF burden and who already have a pacemaker in situ.

Locations

• , , UK

Related clinical trials

• A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
• Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
• STOP AF First Post-Approval Study
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
• Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
• Added Value of Vein of Marshal Ethanol Infusion Compared to Superior Vena Cava Isolation Alone in Patients Undergoing Repeat Ablation for Recurrent Paroxysmal Atrial Fibrillation Despite Durable PV Isolation

View on source registry